Method for Producing a Food Product

Abstract

The present invention relates to a method for producing a heat-treated vegetable-based food product which comprises contacting with asparaginase at high temperature and subsequent drying.

Claims

1-15. (canceled)

16. A method for producing French fries comprising: (a) contacting potato pieces with a solution of an asparaginase at a temperature of 67-75 C.; (b) drying the potato pieces at an air temperature of about 40 to about 90 C.; and (c) heat-treating the asparaginase treated potato pieces to obtain the french fries; wherein the asparaginase: (i) is a variant comprising N70K, S307A, A323R, T327V, A349Q, S351A, and V353I, wherein each position corresponds to a position in SEQ ID NO: 2; (ii) has an amino acid sequence which is at least 80% identical to any of SEQ ID NO: 2 or 4; (iii) has a residual activity measured as asparaginase units per liter (ASNU/L) after 4 hours' incubation in deionized water with 0.5% sodium acid pyrophosphate (SAPP) at 70 C., pH 5, of at least 20% of the activity without such incubation; and (iv) an activity at 35 C., pH 6, of at least 20% of its activity at 50 C. and pH 6.

17. The method of claim 16, wherein the potato pieces comprise potato sticks.

18. The method of claim 16, wherein step (a) is dipping potato pieces into an asparaginase solution having a temperature of about 67-75 C.

19. The method of claim 18, wherein the solution comprises the asparaginase at a concentration of 1,000 to 100,000 asparaginase units (ASNU)/L.

20. The method of claim 19, wherein the solution of the asparaginase further comprises sodium acid pyrophosphate at a concentration of 0.05 to 5%.

21. The method of claim 18, wherein the dipping is for a time of 1 second to 10 minutes.

22. The method of claim 16, further comprising blanching the potato pieces prior to step (a).

23. The method of claim 16, wherein the drying in step (b) is performed at an air temperature of about 55 to about 85 C.

24. The method of claim 16, wherein the surface temperature of potato pieces during drying in step (b) is about 25 to about 60 C.

25. The method of claim 16, wherein the drying in step (b) is performed for between 5 and 30 minutes.

26. The method of claim 16, wherein the acrylamide content of the potato pieces is at least 25% reduced compared to the acrylamide content of potato pieces produced by a similar method without the addition of asparaginase.

27. The method of claim 16, wherein the asparaginase has an activity at 70 C., pH 6, of at least 20% of its activity at 50 C., pH 6.

28. The method of claim 16, wherein the asparaginase has an amino acid sequence which is at least 85% identical to any of SEQ ID NO: 2 or 4.

29. The method of claim 16, wherein the asparaginase has an amino acid sequence which is at least 90% identical to any of SEQ ID NO: 2 or 4.

30. The method of claim 16, wherein the asparaginase has an amino acid sequence which is at least 95% identical to any of SEQ ID NO: 2 or 4.

31. The method of claim 16, wherein the asparaginase has an amino acid sequence which is at least 98% identical to any of SEQ ID NO: 2 or 4.

32. The method of claim 16, wherein the variant is a variant of SEQ ID NO: 2 and comprises a set of mutations selected from the group consisting of: A27*+T28*+D29*+N70K+K122A+P241E+S299A+S307A+A323R+T327V+S334P+P338W+A349Q+S351A+V353I; N70K+K122A+K240R+P241E+K253R+S299A+S307A+A323R+T327V+S334P+E337S+A349Q+S351A+V353I; N70K+K122A+K240R+P241E+K253R+S299A+S307A+A323R+T327V+S334P+A349Q+S351A+V353I; and N70K+K122A+K240R+P241E+S299A+S307A+A323R+T327V+S334P+E337S+A349Q+S351A+V353I.

33. The method of claim 16, wherein the variant is a variant of SEQ ID NO: 2 and comprises a set of mutations selected from the group consisting of: N70K+K122A+K240R+P241E+S299A+S307A+A323R+T327V+S334P+A349Q+S351A+V353I; N70K+K122A+P241E+K290V+S299A+S307A+A323R+T327V+S338W+A349Q+S351A+V353I; N70K+K122A+P241E+K290V+S307A+A323R+T327V+S338W+A349Q+S351A+V353I; and N70K+K122A+P241E+S299A+S307A+A323R+T327V+S334P+A349Q+S351A+V353I.

34. The method of claim 16, wherein the variant is a variant of SEQ ID NO: 2 and comprises a set of mutations selected from the group consisting of: N70K+K122A+P241E+S299A+S307A+A323R+T327V+S334P+E337S+A349Q+S351A+V353I; N70K+K122A+P241E+S299A+S307A+A323R+T327V+S334P+S338W+A349Q+S351A+V353I; N70K+K122A+P241E+S299A+S307A+A323R+T327V+A349Q+S351A+V353I; and N70K+K122A+P241E+S299A+S307A+A323R+T327V+S334W+A349Q+S351A+V353I.

35. The method of claim 16, wherein the variant is a variant of SEQ ID NO: 2 and comprises a set of mutations selected from the group consisting of: N70K+K122A+P241E+5307A+A323R+T327V+5334P+A349Q+5351A+V353I; N70K+K122A+K290V+S307A+A323R+T327V+S334P+S338W+A349Q+S351A+V353I; N70K+K122A+K290V+S307A+A323R+T327V+S338W+A349Q+S351A+V353I; N70K+K122A+S299A+S307A+A323R+T327V+S334P+A349Q+S351A+V353I; N70K+K122A+S307A+A323R+T327V+A349Q+S351A+V353I; N70K+K290V+S307A+A323R+T327V+S338W+A349Q+S351A+V353I; N70K+K290V+S307A+A323R+T327V+A349Q+S351A+V353I; N70K+S297V+S299A+S307A+A323R+T327V+A349Q+S351A+V353I; N70K+S299A+S307A+A323R+T327V+A349Q+S351A+V353I; N70K+S307A+A323R+T327V+S334P+A349Q+S351A+V353I; N70K+S307A+A323R+T327V+S338W+A349Q+S351A+V353I; and N70K+S307A+A323R+T327V+A349Q+S351A+V353I.

Description

DETAILED DESCRIPTION OF THE INVENTION

[0021] SEQ ID NO: 1 is the nucleotide sequence of the asparaginase gene from Aspergillus oryzae. Based on N-terminal sequencing of the mature asparaginase encoded, nucleotides 1-78 encodes the signal sequence. SEQ ID NO: 2 is the amino acid sequence of asparaginase from Aspergillus oryzae. Based on N-terminal sequencing, amino acids 1-26 is the signal sequence. SEQ ID NO: 3 is the nucleotide sequence of a gene encoding a variant of Aspergillus oryzae asparaginase having the following substitutions: N7OK 5307A A323R T327V A349Q S351A V3531. SEQ ID NO: 4 is the amino acid sequence of a variant of Aspergillus oryzae asparaginase having the following substitutions: N7OK 5307A A323R T327V A349Q S351A V3531. SEQ ID NO: 5 is the nucleotide sequence of a gene encoding a variant of Aspergillus oryzae asparaginase having the following substitutions: N7OK A323R T327V A349Q S351A V3531. SEQ ID NO: 6 is the amino acid sequence of a variant of Aspergillus oryzae asparaginase having the following substitutions: N70K A323R T327V A349Q S351A V3531.

[0022] The present invention relates to a method for producing a heat-treated vegetable-based food product comprising:

[0023] (a) contacting of a vegetable-based food material with asparaginase at a temperature of about 67-75 C.;

[0024] (b) drying the vegetable-based food material under conditions where the asparaginase is active; and

[0025] (c) heat-treating the asparaginase treated vegetable-based food material to obtain the heat-treated vegetable-based food product.

[0026] The vegetable-based food material may be any food material based on vegetables which is to be heat-treated. It may be derived from a vegetable tuber or root such as but not limited to the group consisting of potato, sweet potato, yams, yam bean, parsnip, parsley root, Jerusalem artichoke, carrot, radish, turnip, and cassava.

[0027] The processing of a vegetable tuber or root into a suitable vegetable-based food material may comprise, e.g., rinsing, washing, peeling, cutting, etc., such as to produce tuber or root pieces, e.g., potato pieces, of any size and/or shape, e.g., the form of wedges, sticks or slices, e.g., of a size and shape suitable for further processing into a heat-treated vegetable-based food product such as, e.g., French fries.

[0028] In the context of the present invention, French fries is meant to encompass both the final fries ready for consumption and a par-fried pre-product which is to be finally fried or baked before being consumed.

[0029] In a preferred embodiment, the vegetable-based food material is a potato material such as potato pieces, e.g., potato wedges, potato sticks or potato slices. In a more preferred embodiment, the vegetable-based food material is potato wedges or potato sticks. In an even more preferred embodiment, the vegetable-based food material is potato sticks and the heat-treated vegetable-based food product is French fries.

[0030] Preferably, the vegetable-based food material has been blanched before step (a). Blanching may be performed by any method known in the art, e.g., by wet blanching, steam blanching, microwave blanching or infrared blanching.

[0031] In a typical industrial production of French fries, potatoes are initially washed, sorted, steam peeled and cut. Following cutting, the potato sticks are blanched in 2 to 3 sequential steps typically at 65-90 C. for 10-30 min. Blanching is done to inactivate the endogenous enzymes in the potato, to partially cook the potato and to leach out reducing sugars to prevent excessive browning of the final product. After blanching, the potato strips may quickly be dipped, e.g., for 20-180 seconds, in a warm phosphate salt solution, e.g., a warm solution of sodium acid pyrophosphate (SAPP), to prevent greying of the final product. The dip is optionally combined with a dip in glucose to control the final colour. The potatoes may be dried in a drier with hot circulating air at 45-95 C. for 5-20 minutes giving a weight loss of 5-25%. Finally, the potato sticks are parfried before being quick-frozen and packed. Final frying is done at the restaurant or by consumers.

[0032] In the method of the present invention, the contacting with the asparaginase may preferably be combined with dipping in warm phosphate salt solution. I.e., the vegetable based food material, preferably the potato wedges or the potato sticks, more preferably the blanched potato wedges or the blanched potato sticks, is/are dipped or incubated into a solution comprising asparaginase and, e.g., SAPP in one dip bath at a temperature of about 67-75 C. followed by drying. Alternatively, the contacting may be performed by spraying the vegetable-based food material, preferably the potato wedges or the potato sticks, more preferably the blanched potato wedges or the blanched potato sticks, with a solution comprising asparaginase and, e.g., SAPP at a temperature of about 67-75 C. followed by drying.

[0033] In a preferred embodiment, step (a) of the method of the invention is dipping vegetable based food material, preferably potato wedges or potato sticks, more preferably blanched potato wedges or blanched potato sticks, into an asparaginase solution having a temperature of about 67-75 C., preferably about 68-72 C., more preferably about 70 C. The asparaginase solution may comprise asparaginase at a concentration of 1,000 to 100,000 ASNU/L, preferably 5,000 to 50,000 ASNU/L, more preferably 10,000 to 30,000 ASNU/L.

[0034] In a more preferred embodiment, the asparaginase solution further comprises SAPP at a concentration of 0.05 to 5%, preferably 0.1 to 1.5%, more preferably 0.5 to 1%. The asparaginase solution may further comprises glucose, e.g., at a concentration of 0.5 to 2%.

[0035] In a preferred embodiment, dipping is performed for a time of 1 second to 10 minutes, preferably 30 seconds to 3 minutes.

[0036] The drying in step (b) is to be performed at an air temperature of about 40 to about 90 C., preferably about 55 to about 85 C., more preferably about 65 to about 75 C., i.e., under conditions where the asparaginase is active. Drying may be performed in an oven where temperature, humidity and/or air flow can be adjusted to the level(s) desired. Drying may be performed, e.g., for between 5 and 30 minutes.

[0037] Preferably, drying is performed so that the surface temperature of the vegetable-based food material, such as the (blanched) potato wedges or potato sticks, during drying in step (b) is about 25 to about 60 C., preferably about 35 to about 50 C.

[0038] In a preferred embodiment, the acrylamide content of the heat-treated vegetable-based food product is at least 25% reduced, preferably at least 30%, at least 35%, at least 40%, at least 45% or at least 50% reduced, compared to the acrylamide content of a heat-treated vegetable-based food product produced by a similar method without the addition of asparaginase.

[0039] In a more preferred embodiment, the vegetable-based food material is potato sticks, the heat-treated vegetable-based food product is French fries, and the acrylamide content of the French fries is at least 25% reduced, preferably at least 30%, at least 35%, at least 40%, at least 45% or at least 50% reduced, compared to the acrylamide content of French fries produced by a similar method without the addition of asparaginase.

[0040] The acrylamide content may be determined by any method known in the art, e.g., by the method described in Example 3.

[0041] The invention further relates to a use of asparaginase for treatment of a vegetable-based food material at a temperature of about 67-75 C.

[0042] An asparaginase in the context of the present invention means an enzyme having asparaginase activity, i.e., an enzyme that catalyzes the hydrolysis of asparagine to aspartic acid (EC 3.5.1.1).

[0043] Asparaginase activity may be determined according to one of the asparaginase activity assays described in the Examples, e.g., by the ASNU assay. In one embodiment, an asparaginase to be used in the method of the present invention has at least 20%, e.g., at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 95%, or at least 100% of the asparaginase activity of the mature polypeptide of SEQ ID NO: 2 when measured at pH 7 and at 37 C.

[0044] The asparaginase may be a microbial asparaginase, e.g., an asparaginase derived from a bacterium, an archaeon or a fungus. It may be a wild type asparaginase, i.e., an asparaginase found in nature, or it may be a variant asparaginase, i.e., an asparaginase comprising an alteration, i.e., a substitution, insertion, and/or deletion, at one or more (e.g., several) positions compared to a parent asparaginase from which it may have been derived. A substitution means replacement of the amino acid occupying a position with a different amino acid; a deletion means removal of the amino acid occupying a position; and an insertion means adding an amino acid adjacent to and immediately following the amino acid occupying a position.

[0045] An asparaginase to be used according to the invention has a residual activity after 4 hours' incubation in deionized water with 0.5% SAPP at 70 C., pH 5, of at least 20%, preferably at least 40%, more preferably at least 60%, even more preferably at least 80%, of the activity without such incubation. The asparaginase activity may be determined by the rASNU assay as described in the Examples. It may be determined at pH 6 and at 37 C.

[0046] Preferably, an asparaginase to be used according to the invention has a residual activity after 4 hours' incubation in deionized water with 0.5% SAPP at 72 C., pH 5, of at least 5%, preferably at least 10%, more preferably at least 20%, even more preferably at least 40%, such as at least 60% or at least 80%, of the activity without such incubation.

[0047] Preferably, an asparaginase to be used according to the invention has a residual activity after 4 hours' incubation in deionized water with 0.5% SAPP at 74 C., pH 5, of at least 1%, preferably at least 5%, more preferably at least 10%, even more preferably at least 20%, such as at least 40% or at least 60%, of the activity without such incubation.

[0048] An asparaginase to be used according to the invention has an activity at 35 C., pH 6, of at least 20%, preferably at least 30%, more preferably at least 35%, of its activity at 50 C., pH 6.

[0049] Preferably, the asparaginase has an activity at 70 C., pH 6, of at least 20%, preferably preferably at least 25%, more preferably at least 30%, of its activity at 50 C., pH 6.

[0050] More preferably, the asparaginase has (i) an activity at 35 C., pH 6, of at least 20%, preferably at least 30%, more preferably at least 35%, of its activity at 50 C., pH 6, and (ii) an activity at 70 C., pH 6, of at least 20%, preferably at least 25%, more preferably at least 30%, of its activity at 50 C., pH 6.

[0051] Preferably, the asparaginase has an activity at pH 5 of at least 20%, preferably at least 30%, more preferably at least 40%, even more preferably at least 50%, of its activity at pH 6.5. The activity may be determined at 50 C.

[0052] More preferably, the asparaginase has (i) an activity at 35 C., pH 6, of at least 20%, preferably at least 30%, more preferably at least 35%, of its activity at 50 C., pH 6, (ii) an activity at 70 C., pH 6, of at least 20%, preferably at least 25%, more preferably at least 30%, of its activity at 50 C., pH 6, and (iii) an activity at pH 5, 50 C., of at least 20%, preferably at least 30%, more preferably at least 40%, even more preferably at least 50%, of its activity at pH 6.5, 50 C.

[0053] Preferably, the asparaginase has a residual activity after 2 hours' incubation in deionized water with 0.5% SAPP at pH 4 and 70 C. of at least 20%, preferably at least 30%, more preferably at least 40%, even more preferably at least 50%, of the activity without such incubation.

[0054] In one embodiment, the asparaginase is obtained from, or is a variant of a parent asparaginase obtained from, a microorganism of any genus. For purposes of the present invention, the term obtained from as used herein in connection with a given source shall mean that the parent encoded by a polynucleotide is produced by the source or by a strain in which the polynucleotide from the source has been inserted. In one embodiment, the parent is secreted extracellularly.

[0055] The asparaginase or its parent may be a fungal asparaginase. It may be a filamentous fungal asparaginase such as an Acremonium, Agaricus, Alternaria, Aspergillus, Aureobasidium, Botryospaeria, Botryotinia, Ceriporiopsis, Chaetomidium, Chrysosporium, Claviceps, Cochliobolus, Coprinopsis, Coptotermes, Corynascus, Cryphonectria, Cryptococcus, Diplodia, Exidia, Filibasidium, Fusarium, Gibberella, Holomastigotoides, Humicola, Irpex, Lentinula, Leptospaeria, Magnaporthe, Melanocarpus, Meripilus, Mucor, Myceliophthora, Neocallimastix, Neosartorya, Neurospora, Paecilomyces, Penicillium, Phanerochaete, Piromyces, Poitrasia, Pseudoplectania, Pseudotrichonympha, Rhizomucor, Schizophyllum, Sclerotinia, Scytalidium, Talaromyces, Thermoascus, Thielavia, Tolypocladium, Trichoderma, Trichophaea, Verticillium, Volvariella, or Xylaria asparaginase.

[0056] In one embodiment, the asparaginase or its parent is an Acremonium cellulolyticus, Aspergillus aculeatus, Aspergillus awamori, Aspergillus foetidus, Aspergillus fumigatus, Aspergillus japonicus, Aspergillus nidulans, Aspergillus niger, Aspergillus oryzae, Aspergillus terreus, Botryotinia fuckeliana, Chrysosporium inops, Chrysosporium keratinophilum, Chrysosporium lucknowense, Chrysosporium merdarium, Chrysosporium pannicola, Chrysosporium queenslandicum, Chrysosporium tropicum, Chrysosporium zonatum, Fusarium bactridioides, Fusarium cerealis, Fusarium crookwellense, Fusarium culmorum, Fusarium graminearum, Fusarium graminum, Fusarium heterosporum, Fusarium negundi, Fusarium oxysporum, Fusarium reticulatum, Fusarium roseum, Fusarium sambucinum, Fusarium sarcochroum, Fusarium sporotrichioides, Fusarium sulphureum, Fusarium torulosum, Fusarium trichothecioides, Fusarium venenatum, Humicola grisea, Humicola insolens, Humicola lanuginosa, Irpex lacteus, Mucor miehei, Myceliophthora thermophila, Neosartorya fischeri, Neurospora crassa, Penicillium chrysogenum, Penicillium citrinum, Penicillium funiculosum, Penicillium purpurogenum, Phanerochaete chrysosporium, Sclerotinia sclerotiorum, Thielavia achromatica, Thielavia albomyces, Thielavia albopilosa, Thielavia australeinsis, Thielavia fimeti, Thielavia microspora, Thielavia ovispora, Thielavia peruviana, Thielavia setosa, Thielavia spededonium, Thielavia subthermophila, Thielavia terrestris, Trichoderma harzianum, Trichoderma koningii, Trichoderma longibrachiatum, Trichoderma reesei, or Trichoderma viride asparaginase.

[0057] In one preferred embodiment, the asparaginase is a variant of a parent asparaginase obtainable from Aspergillus, e.g., from Aspergillus aculleatus, Aspergillus awamori, Aspergillus foetidus, Aspergillus fumigatus, Aspergillus japonicus, Aspergillus nidulans, Aspergillus niger, Aspergillus oryzae or Aspergillus terreus. Preferably, it is a variant having an increased thermostability as compared to its parent. The thermostability may be determined as described in Example 1.

[0058] In another preferred embodiment, the asparaginase is a variant of a parent asparaginase obtainable from Aspergillus oryzae, e.g., the asparaginase of SEQ ID NO: 2 or the mature polypeptide thereof, or a variant of a parent asparaginase obtainable from Aspergillus niger, e.g., the asparaginase disclosed in WO 2004/030468.

[0059] In another preferred embodiment, the asparaginase has an amino acid sequence which is at least 50% identical to any of SEQ ID NO: 2 or 4, preferably at least 60%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95% or at least 98% identical to any of SEQ ID NO: 2 or 4.

[0060] In another preferred embodiment, the asparaginase is a variant of a parent asparaginase having an amino acid sequence which is at least 50% identical to any of SEQ ID NO: 2 or 4, preferably at least 60%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98% or 100% identical to any of SEQ ID NO: 2 or 4.

[0061] In another preferred embodiment, the asparaginase is an asparaginase variant comprising a substitution at one or more positions corresponding to positions 122, 140, 197, 238, 239, 240, 241, 253, 258, 259, 297 or 373 of SEQ ID NO: 2, and having an amino acid sequence which is at least 50% identical to any of SEQ ID NO: 2 or 4, preferably at least 60%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95% or at least 98% identical to any of SEQ ID NO: 2 or 4.

[0062] In another preferred embodiment, the asparaginase is an asparaginase variant comprising (i) one or more of the following substitutions, wherein each position corresponds to a position in SEQ ID NO: 2: T71C, T74A, T74C, K122A, K122R, V139G, T140D, K194L, D197E, I228M, S238C, N239C, K240R, P241E, K253R, I258V, I258Y, R259C, R259V, S297V, S299A, T314A, P333L, S334P, S334W, E337S, S338G, S338W, G356D, K363R or E373H, or (ii) a deletion at one or more positions corresponding to positions 27, 28 or 29 of SEQ ID NO: 2; wherein the asparaginase variant has an amino acid sequence which is at least 50% identical to any of SEQ ID NO: 2 or 4, preferably at least 60%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95% or at least 98% identical to any of SEQ ID NO: 2 or 4.

[0063] In another preferred embodiment, the asparaginase is an asparaginase variant comprising (i) one or more of the following substitutions, wherein each position corresponds to a position in SEQ ID NO: 2: T71C, T74A, T74C, K122A, K122R, V139G, T140D, K194L, D197E, I228M, S238C, N239C, K240R, P241E, K253R, I258V, I258Y, R259C, R259V, S297V, S299A, T314A, P333L, S334P, S334W, E337S, S338G, S338W, G356D, K363R or E373H, or (ii) a deletion at one or more positions corresponding to positions 27, 28 or 29 of SEQ ID NO: 2; wherein the asparaginase variant has an amino acid sequence which is at least 50% identical to SEQ ID NO: 4, preferably at least 60%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95% or at least 98% identical to SEQ ID NO: 4.

[0064] In another preferred embodiment, the asparaginase is an asparaginase variant comprising one or more of the following substitutions, wherein each position corresponds to a position in SEQ ID NO: 2: T71C, T74A, T74C, K122A, K122R, V139G, T140D, K194L, D197E, 1228M, S238C, N239C, K240R, P241E, K253R, 1258V, 1258Y, R259C, R259V, S297V, S299A, T314A, P333L, S334P, S334W, E337S, S338G, S338W, G356D, K363R or E373H; wherein the asparaginase variant has an amino acid sequence which is at least 50% identical to SEQ ID NO: 4, preferably at least 60%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95% or at least 98% identical to SEQ ID NO: 4.

[0065] In another preferred embodiment, the asparaginase is an asparaginase variant comprising one or more of the following substitutions, wherein each position corresponds to a position in SEQ ID NO: 2: T74A, K122A, K122R, K194L, K240R, P241E, S299A, S334P, S334W, E337S or S338W; wherein the asparaginase variant has an amino acid sequence which is at least 50% identical to SEQ ID NO: 4, preferably at least 60%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95% or at least 98% identical to SEQ ID NO: 4.

[0066] In another preferred embodiment, the asparaginase is an asparaginase variant comprising one or more of the following substitutions, wherein each position corresponds to a position in SEQ ID NO: 2: K122A, K240R, P241E, S299A, S334P, E337S or S338W; wherein the asparaginase variant has an amino acid sequence which is at least 50% identical to SEQ ID NO: 4, preferably at least 60%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95% or at least 98% identical to SEQ ID NO: 4.

[0067] In another preferred embodiment, the asparaginase is an asparaginase variant disclosed in EP Patent Application No. 12180861 filed 17 Aug. 2012 which is hereby incorporated by reference.

EXAMPLES

Materials and Methods

[0068] Asparaginase activity (ASNU) Assay

[0069] The activity of asparaginase may be measured in ASNU. An asparaginase unit (ASNU) is defined as the amount of enzyme needed to generate 1.0 micromole of ammonia in 1 minute at 37 C. and pH 7.0, in 0.1 M MOPS buffer with 9.2 mg/ml asparagine.

[0070] Asparaginase hydrolyzes asparagine to aspartic acid and ammonium. The produced ammonium is combined with a-ketoglutarate to form glutamic acid whereby NADH is oxidized to NAD+. The reaction is catalysed by a surplus of glutamate dehydrogenase. The consumption of NADH is measured by photometry at 340 nm. NADH has an absorbance at 340 nm, while NAD+ has no absorbance. A decrease in color is thus measured, and can be correlated to asparaginase activity.

[0071] Activity is determined relative to an asparaginase standard of known activity. A commercial product having a declared activity like Acrylaway L may be used as standard.

Asparaginase Activity Assayused in Examples 1 and 2

Principle:

[0072] Asparaginase hydrolyzes asparagine to aspartic acid and ammonium. Produced ammonium is determined using Nessler's reagent.

[0073] Activity is determined relative to a standard of known activity in ASNU or to a relevant control sample. Activity as determined according to this assay is referred to as nASNU.

Enzyme Incubation:

[0074]

TABLE-US-00001 Temperature 37 C. pH 6.0 Buffer 20 mM citric acid, pH 6 + 0.001% triton x-100 Asparagine 25 mg/ml in buffer substrate sol. Stop reagent 1.5M Trichloroacetic acid (TCA) Enzyme Standard 0-20 ASNU/ml The enzyme dilutions are made in buffer. Incubation time 10 min

Procedure:

[0075]

TABLE-US-00002 Buffer 750 L Asparagine (25 mg/mL) 100 L Sample 100 L 1.5M TCA (stop reagent) 50 L Total volume 1.000 L

[0076] Mix buffer and asparagine and let it equilibrate at 37 C. for 10-15 min. Add enzyme standard or sample and incubate for 10 min at 37 C. Add TCA to stop the reaction.

Ammonium Determination (Nessler Assay):

[0077]

TABLE-US-00003 Temperature Ambient pH ~12, controlled by addition of Nesslers reagent Nessler's reagent Mercury(II)chloride, potassium iodide, potassium hydroxide Incubation time 10 min A.sub.436 Endpoint measurement at 440 nm

Procedure:

[0078]

TABLE-US-00004 Microtiter plate MQ Water 140 L Sample 20 L Nessler's reagent 40 L Total volume 200 L

[0079] MQ water, sample and Nessler's reagent is added to the microtiter plate. Shake for 10 sec and then leave to incubate for 10 min before shaking again and reading at 440 nm.

Asparaginase Activity Assay (rASNU Assay)used in Examples 4, 5, 6 and 7

Reagents:

[0080] 1 M Potassium phosphate buffer (pH6.0)

[0081] 1 M KH.sub.2PO.sub.4 (136 g/500 ml)+1 M K.sub.2HPO.sub.4 (174 g/500 ml)

[0082] Adjust to pH 6.0 [0083] 100 mM Potassium phosphate buffer (pH 6.0)+0.1% tritonX-100 (1 L)

[0084] 100 ml 1 M Potassium phosphate buffer (pH 6.0)

[0085] 1 g Triton X-100

[0086] Adjust to 1000 ml [0087] 2 M Hydroxylamine (HA) solution (100 ml)

[0088] 13.9 g hydroxylamine

[0089] Adjust to 100 ml with 100 mM potassium phosphate buffer (pH 6) [0090] Stop solution (500 ml)

[0091] 23.83 ml acetate

[0092] 13.88 g FeCl.sub.3 6 H.sub.2O

[0093] 84 ml 5 N HCl

[0094] Adjust to 500 ml with H.sub.2O [0095] Substrate solution (100 ml)

[0096] 10 ml 1 M Potassium phosphate buffer

[0097] 0.5 g L-asparagine

[0098] 5 ml 2 M HA soln.

[0099] Adjust to 100 ml with H.sub.2O

Activity Assay:

[0100] 1 Pipette 20 microL sample into a well. [0101] 2 Add 100 microL of substrate solution into the well. [0102] 3 Incubate 20 min. at 55 C. (or as otherwise indicated). [0103] 4 Add 100 microL of stop solution into the well. [0104] 5 Measure A490.

[0105] Compare result to that of a control for a relative effect or to a standard of known activity in ASNU. Activity as determined according to this assay is referred to as rASNU.

Asparaginase Enzymes

[0106] JN065N2 is a variant of wild type Aspergillus oryzae asparaginase described in WO 2008/110513 having the following amino acid substitutions: N7OK A323R T327V A349Q S351A V3531 as compared to the amino acid sequence of the wild type.

[0107] JN070 is a variant of JN065N2 which further has the amino acid substitution 5307A, i.e., it has the following amino acid substitutions as compared to the amino acid sequence of wild type Aspergillus oryzae asparaginase: N70K 5307A A323R T327V A349Q S351A V353I.

[0108] The following variants (Table 0) of JN070 are used in the present Examples. For the avoidance of any possible doubt: for example, the variant JN102 has the following amino acid substitutions as compared to the amino acid sequence of wild type Aspergillus oryzae asparaginase: N70K K122A S307A A323R T327V A349Q S351A V353I.

TABLE-US-00005 TABLE 0 Variants of JN070 Substitutions to JN070 JN102 K122A JN117 K290V JN135 S297V S299A JN140 S334P JN145 S338W JN148 K290V S338W JN152 S299A JN158 K122A P241E S299A JN159 K122A K290V S338W JN161 K122A P241E K290V S299A S338W JN162 K122A P241E K290V S338W JN165 K122A S299A S334P JN166 K122A P241E S334P JN167 K122A P241E S299A S334P JN168 K122A K290V S334P S338W JN178 K122A K240R P241E S299A S334P JN179 K122A K240R P241E K253R S299A S334P JN180 K122A K240R P241E S299A S334P E337S JN181 K122A K240R P241E K253R S299A S334P E337S JN182 K122A P241E S299A S334P E337S JN183 K122A P241E S299A S334P S338W JN184 K122A P241E S299A S334W JN226 A27* T28* D29* K122A P241E S299A S334P S338W

Example 1

[0109] Thermostability in Potato Blanching Water with SAPP

[0110] 0.5% SAPP was added to potato blanching water(=4 L deionized water which has been used for blanching of 2400 g potatoes at 85 C. (16 portions of 150 g for 4 min each)) and pH adjusted to pH 5. This solution is intended to mimic a SAPP solution used for continuous chemical dip treatment of French fries.

[0111] The thermostability of the different asparaginase variants was tested in this solution at 70 C.: Each asparaginase variant used at an enzyme dose of 10,000 ASNU/L was incubated in 20 ml of potato blanching water with SAPP at 70 C. for 4 hrs. Samples were taken every -1 hr for a total period of 4 hrs and enzyme activity analysed. Results are shown below.

TABLE-US-00006 TABLE 1 Residual activity after 4 hrs incubation in potato blanching water with SAPP at 70 C. compared to the initial activity at time 0. % Sample Residual act. JN102 58 JN117 53 JN135 100 JN140 47 JN145 81 JN148 71 JN152 80 JN158 103 JN159 72 JN161 108 JN162 124 JN165 99 JN166 108 JN167 103 JN168 111 JN178 97 JN179 90 JN180 114 JN181 84 JN182 84 JN183 109 JN184 100 JN226 114

[0112] As seen from the table all variants show increased stability at 70 C. compared to the wt Aspergillus oryzae asparaginase which has <10% residual activity at similar conditions.

Example 2

Comparing Thermostability of the Thermostable Variants and the wt Enzyme in Continuous Treatment of French Fries for Acrylamide Mitigation

[0113] French fry potatoes (Maris Piper or Bintje) were manually peeled and cut into French fries (size 0.80.85 cm) using a French fry cutter (Coupe Frites). The potato sticks from the individual potatoes were mixed and held in de-ionized water until use. Portions of 20 g of potato sticks were blanched in two steps; first at 85 C. for 4 min (4 L deionized water that was reused) and subsequently in 250 ml deionized water at 70 C. for 15 minutes (fresh water for each sample). Enzyme treatment was done by holding the blanched potato sticks for 5 min at 70 C. in 200 ml enzyme solution (0.5% SAPP in deionized water) dosing 10,000 ASNU/L of the variants or the wt enzyme. Every 5 min a new portion of blanched potato sticks was dipped in the enzyme bath in order to mimic continuous use of the enzyme bath. Samples from the enzyme bath were taken every 30 min for a total period of 4 hours and frozen for later activity analysis.

[0114] Results are shown below.

TABLE-US-00007 TABLE 2 Residual activity of enzyme solution after 4 hrs continuous use at 70 C. of dipping freshly blanched potato strips and holding each portion for 5 min. Residual activity after 4 hrs is calculated as a percentage of the initial measured activity at t = 0. % Sample Residual act. JN102 81 JN117 107 JN135 83 JN140 73 JN145 87 JN148 85 JN152 77 JN158 112 JN159 86 JN161 80 JN165 122 JN166 108 JN167 73 JN168 80 JN179 111 JN181 100 JN182 100 JN183 108 JN184 128 JN226 121 wt 8

[0115] As seen from the table the variants show a significant increase in stability at 70 C. compared to the wt enzyme also under conditions of continuous use in an application set-up.

Example 3

Application Performance of the Thermostable Variants in Treatment of French Fries for Acrylamide Mitigation

[0116] French fry potatoes (Maris Piper or Bintje) were manually peeled and cut into French fries (size 0.80.85 cm) using a French fry cutter (Coupe Frites). The potato sticks from the individual potatoes were mixed and held in de-ionized water until use. Portions of 75 g potato sticks were blanched in two steps; first at 85 C. for 4 min (4 L deionized water that was reused) and subsequently in 250 ml deionized water at 70 C. for 15 minutes (fresh water for each sample). Enzyme treatment was done by dipping the blanched potato sticks for 1 min at 70 C. in 250 ml enzyme solution (0.5% Sodium Acid Pyrophosphate, pH 5 in deionized water) using a dosage of 10,000 ASNU/L of the variants. For comparison a control sample dipped in 0.5% SAPP without enzyme was included. Testing of the wt enzyme was done at 55 C. to ensure activity. Samples were made in triplicate. After enzyme treatment the potato sticks were dried in a ventilated heating cupboard for 10 min at 85 C., 20% RH (relative humidity), and parfried in vegetable oil for 1 min at 175 C. The samples were blast frozen and finally second fried 3 min at 175 C.

[0117] The fries were blended and the acrylamide extracted using acetonitrile and an Automated Solvent Extractor (ASE from Dionex). The extract was treated with Carrez solution I and II (Carrez solution I contains 15 g/100 ml of potassium hexacyanoferrate(II) trihydrate (K.sub.4[Fe(CN).sub.6]3H.sub.2O); Carrez solution II contains 30 g/100 ml of zinc sulfate heptahydrate (ZnSO.sub.47H.sub.2O)), left overnight in the fridge and filtered using a 0.22 m filter before HPLC analysis (column: Dionex IonPac ICE-AS1, 9250 mm, eluent: 5 mM HCl, detection: UV 202 nm). Acrylamide was identified and quantified by comparing with known standards.

[0118] Results are given below.

TABLE-US-00008 TABLE 3 Calculated reduction in acrylamide formation in final French fries treated with the different variants at a fixed dose of 10,000 ASNU/L and a dip temperature of 70 C. Reduction is calculated by comparing to a control sample dipped in SAPP without enzyme. For the wt enzyme treatmentwas done at a dip temperature of 55 and 70 C. Duplicate numbers are from separate repeated trials. Reduction vs. Control Treatment sample, % Control 0 wt (55 C.) 45 wt (70 C.) 1 JN135 53 JN140 55 JN145 35 JN152 54/50 JN158 52 JN159 49 JN161 41 JN165 37 JN166 36 JN167 46 JN168 42 JN178 41 JN179 51 JN180 52 JN181 51/51 JN182 51/49 JN183 48 JN184 47 JN226 61

[0119] Acrylamide in the final French fry product has been reduced by approximately 50% showing that the variants are active in the application. For the wildtype enzyme the achieved reductions in acrylamide levels were 45% at 55 C. and 1% at 70 C.

Example 4

Temperature Activity

[0120] Purified enzyme was diluted with 20 mM sodium acetate buffer pH 5.5 to a concentration around 2 rASNU/ml. Ten microliters of enzyme solution was added to 100 microL of substrate solution, which has been pre-incubated at different temperature, of rASNU assay in a 96-well PCR plate and incubated for 20 min. The reaction was stopped by adding 100 microL of stop solution and the absorbance at 490 nm was measured.

TABLE-US-00009 TABLE 4 Temperature activity in percentage of activity at 50 C. Variant Thermoactivity (100% @ 50 C.) No. 35 C. 60 C. 70 C. WT 78% 64% 4% JN065 67% 68% 24% JN070 64% 68% 25% JN117 63% 69% 30% JN135 79% 72% 29% JN140 69% 67% 34% JN145 72% 68% 25% JN148 67% 75% 29% JN152 57% 79% 35% JN158 51% 79% 38% JN159 67% 68% 27% JN161 51% 82% 39% JN162 63% 73% 31% JN165 55% 77% 38% JN166 63% 69% 30% JN167 53% 83% 42% JN168 71% 71% 31% JN178 50% 83% 42% JN179 45% 83% 41% JN180 39% 92% 51% JN181 38% 96% 52% JN182 41% 92% 50% JN183 57% 77% 37% JN184 58% 92% 46% JN226 59% 84% 41%

Example 5

pH Activity

[0121] Purified enzymes were diluted with 20 mM sodium acetate buffer pH 5.5 to a concentration around 2 rASNU/ml. Ten microliters of enzyme solution was added to 100 microL of preincubated substrate solution with different pH constructed by mixing 2-fold substrate solution of rASNU assay and equal volume of 200 mM Britton-Robinson buffer (pH 2.5-11.5). After 20 min incubation at 50 C., the reaction was stopped by adding 100 microL of stop solution and the absorbance at 490 nm was measured.

TABLE-US-00010 TABLE 5 pH activity Variant pH activity No. pH 5/pH 6.5 @ 50 C. WT 36% JN065 41% JN070 44% JN102 45% JN117 47% JN135 29% JN140 50% JN145 43% JN148 44% JN152 52% JN158 53% JN159 45% JN161 55% JN162 45% JN165 61% JN166 51% JN167 59% JN168 53% JN178 59% JN179 57% JN180 64% JN181 62% JN182 58% JN183 60% JN184 55% JN226 62%

Example 6

pH Stability at 70 C.

[0122] Purified enzyme was diluted with 0.5% SAPP pH 4.0-7.0 (pH was adjusted using HCl or NaOH) to a concentration around 6 rASNU/ml. Fifty microliters of diluted enzyme solution was transferred to 96-well PCR plate and incubated at 70 C. for 2 hours. Immediately after incubation, 10 microL of incubated solution was added to 100 microL of preincubated substrate solution of rASNU assay in a 96-well plate and incubated at 50 C. for 20 min. The reaction was stopped by adding 100 microL of stop solution and the absorbance at 490 nm was measured. The residual activity was determined using the activity of a similar sample incubated at 25 C. as a control.

TABLE-US-00011 TABLE 6 pH stability Variant pH stability @ 70 C., 2 h No. pH 4 pH 5 pH 6 pH 7 WT 0% 0% 0% 0% JN065 10% 12% 0% 0% JN070 68% 55% 0% 0% JN102 62% 64% 0% 0% JN117 77% 78% 0% 0% JN135 93% 94% 10% 0% JN140 74% 77% 28% 0% JN145 93% 99% 46% 0% JN148 77% 80% 44% 0% JN152 91% 92% 27% 0% JN158 93% 98% 73% 0% JN159 87% 91% 69% 0% JN161 98% 100% 94% 74% JN162 98% 102% 93% 1% JN165 98% 100% 84% 2% JN166 95% 98% 81% 0% JN167 105% 103% 92% 40% JN168 108% 105% 95% 12% JN178 105% 106% 99% 37% JN179 109% 104% 94% 4% JN180 109% 116% 102% 74% JN181 110% 112% 100% 38% JN182 109% 112% 101% 74% JN183 106% 104% 98% 75% JN184 94% 84% 54% 0% JN226 99% 99% 92% 80%

Example 7

Enzyme Thermostability in 0.5% SAPP

[0123] Purified enzyme was diluted with 0.5% sodium dihydrogen pyrophosphate (SAPP) pH 5.0 to a concentration around 6 rASNU/ml. Fifty microliters of diluted enzyme solution was transferred to a 96-well PCR plate and incubated at 70-80 C. for 4 hours by using a thermal cycler. Immediately after incubation, 10 microL of incubated solution was added to 100 microL of pre-incubated substrate solution of rASNU assay in a 96-well plate and incubated at 37 or 50 C. for 20 min. The reaction was stopped by adding 100 microL of stop solution and the absorbance at 490 nm was measured. The residual activity was determined using the activity of a similar sample incubated at 25 C. as a control.

TABLE-US-00012 TABLE 7 Residual activity after 4 hours residual after 4 h in 0.5% SAPP, pH 5 Variant No. 70 C. 72 C. 74 C. 76 C. 78 C. 80 C. WT 1% 1% JN065 1% 2% JN070 35% 1% 2% 1% 1% JN102 53% 6% 2% 2% 1% JN117 61% 6% 1% 1% 1% JN135 88% 72% 21% 1% 1% JN140 67% 52% 21% 2% 1% JN145 90% 71% 17% 2% 1% JN148 74% 62% 26% 2% 1% JN152 79% 67% 25% 0% 0% JN158 93% 79% 67% 43% 2% JN159 86% 75% 47% 3% 0% JN161 100% 99% 95% 77% 71% JN162 102% 97% 91% 50% 1% JN165 98% 92% 80% 64% 37% JN166 100% 95% 85% 61% 9% JN167 103% 101% 97% 82% 68% JN168 104% 97% 87% 72% 25% JN178 103% 103% 99% 92% 78% 33% JN179 93% 87% 81% 74% 53% 10% JN180 100% 106% 104% 96% 83% 64% JN181 100% 100% 96% 87% 72% 35% JN182 101% 102% 99% 94% 76% 59% JN183 99% 100% 98% 94% 76% 62% JN184 94% 87% 64% 48% 22% 0% JN226 100% 103% 102% 96% 90% 76%